Royalty Pharma plc

Historical 13F Holders

Symbol
RPRX
CUSIP
G7709Q104
All holders as of
Q1 2026
Type
Equity
Class
SHS CLASS A
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 188 24.5 M $1.38 B
2026 Q1 601 314 M $14.9 B
2025 Q4 553 303 M $11.7 B
2025 Q3 508 331 M $11.7 B
2025 Q2 479 343 M $12.4 B
2025 Q1 475 323 M $10.1 B
2024 Q4 432 322 M $8.22 B
2024 Q3 409 316 M $8.93 B
2024 Q2 393 369 M $9.72 B
2024 Q1 396 410 M $12.4 B
2023 Q4 378 369 M $10.4 B
2023 Q3 331 301 M $8.17 B
2023 Q2 339 320 M $9.32 B
2023 Q1 348 302 M $10.9 B
2022 Q4 351 308 M $12.1 B
2022 Q3 335 301 M $12.1 B
2022 Q2 298 292 M $12.3 B
2022 Q1 296 271 M $10.5 B
2021 Q4 285 268 M $10.7 B
2021 Q3 247 265 M $9.59 B
2021 Q2 254 250 M $10.3 B
2021 Q1 233 248 M $15.0 B
2020 Q4 219 231 M $13.4 B
2020 Q3 145 159 M $8.19 B
2020 Q2 127 150 M $8.96 B
2020 Q1 1 15.0 $1.00 k
2019 Q4 1 15.0 $1.00 k
2019 Q3 1 15.0 $1.00 k
2019 Q2 1 15.0 $1.00 k
2019 Q1 1 15.0 $1.00 k